BioMed Research International

Volume 2014 (2014), Article ID 963156, 11 pages

http://dx.doi.org/10.1155/2014/963156

Research Article

Cigarette Smoke-Exposed Candida albicans Increased Chitin Production and Modulated Human Fibroblast Cell Responses

Humidah Alanazi,¹ Abdelhabib Semlali,1,2 Laura Perraud,¹ Witold Chmielewski,¹ Andrew Zakrzewski,¹ and Mahmoud Rouabhia¹

¹Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Université Laval, 2420 rue de la Terrasse, Québec, QC, Canada, G1V 0A6

²Genome Research Chair, Department of Biochemistry, College of Science, King Saud University, Riyadh 12371, Saudi Arabia

Received 24 July 2014; Revised 29 August 2014; Accepted 29 August 2014; Published 11 September 2014

Academic Editor: John B. Vincent

Copyright © 2014 Humidah Alanazi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

The predisposition of cigarette smokers for development of respiratory and oral bacterial infections is well documented. Cigarette smoke can also contribute to yeast infection. The aim of this study was to investigate the effect of cigarette smoke condensate (CSC) on C. albicans transition, chitin content, and response to environmental stress and to examine the interaction between CSC-pretreated C. albicans and normal human gingival fibroblasts. Following exposure to CSC, C. albicans transition from blastospore to hyphal form increased. CSC-pretreated yeast cells became significantly () sensitive to oxidation but significantly () resistant to both osmotic and heat stress. CSC-pretreated C. albicans expressed high levels of chitin, with 2- to 8-fold recorded under hyphal conditions. CSC-pretreated C. albicans adhered better to the gingival fibroblasts, proliferated almost three times more and adapted into hyphae, while the gingival fibroblasts recorded a significantly () slow growth rate but a significantly higher level of IL-1β when in contact with CSC-pretreated C. albicans. CSC was thus able to modulate both C. albicans transition through the cell wall chitin content and the interaction between C. albicans and normal human gingival fibroblasts. These findings may be relevant to fungal infections in the oral cavity in smokers.

1. Introduction

Mucosal candidiasis, especially the oropharyngeal type (OPC), is a common opportunistic infection in both immunocompromised and immunocompetent persons [1]. The leading cause of candidiasis is Candida albicans, a commensal dimorphic yeast that colonizes up to 60% of normally healthy individuals [2]. Symptomatic OPC appears under a number of predisposing conditions [3, 4]. From these, tobacco smoking was considered predisposing to oral candidiasis [5]. Indeed, epidemiological studies in immunocompromised patients have identified tobacco as a major risk factor for symptomatic infection [6, 7]. Furthermore, the rate of oral candidal carriage in tobacco smokers was reported to be higher in smokers than in nonsmokers [8, 9]. This may explain why 98% of Indian villager’s smokers suffer candidal leukoplakia that can be resolved after cessation of tobacco [10, 11].

The exact mechanism by which candidal carriage may be affected by tobacco is still to be discovered. Previous studies have demonstrated that smoking leads to innate immune reduction facilitating candida colonization and host infection [12]. This may suggest the use of tobacco compounds by C. albicans as nutritional factors, since aromatic hydrocarbons contained in cigarette smoke can be converted by Candida species to carcinogen end products [13]. It has also been reported that C. albicans can catalyze the formation of N-nitrosobenzylmethylamine supporting the high candidal leukoplakia level in smokers [14].

During the development of candidiasis, C. albicans adheres to and invades the tissue [15, 16]. Tis adhesion is promoted by yeast cell wall proteins [17]. Candida cell walls contain glucans, mannans, glycoproteins, and chitins [18–20]. In C. albicans, three genes encoding different chitin synthases (CHS1, 2, and 3) were identified. Chitin production is dependent on the experimental culture condition. Indeed, the CHS2 and CHS3 are preferentially expressed under hyphal culture condition [21, 22], whereas CHS1 remained at low levels in both yeast and hyphae [23]. Interestingly, Chs1p was found to be essential for cell integrity and virulence [23]. Mutants defective in chitin proteins are less virulent than the parental strain in a mouse model. Thus, with high level of chitin, C. albicans can overcome cigarette smoke effects and escape the host immune defense [22].

Gingival fibroblasts are major actor in the host immune defense against Candida infection [24, 25]. Gingival fibroblasts play role in tissue structure and function [26]. They are active in the inflammatory response by secreting inflammatory cytokines, such as IL-6 and IL-8, as well as IL-1β in response to stimuli that include periodontopathic bacteria [27, 28]. The secretion of these cytokines may, thus, be modulated when fibroblasts are exposed to cigarette smoke.

Exposure to smoke-derived toxicants has been shown to lead to immune dysfunction [29]. Smokers thus run a greater risk of contracting invasive diseases caused by various bacterial pathogens [30–32]. Exposure to cigarette smoke has also been shown to induce the formation of biofilm by various oral/respiratory pathogens in vitro, including P. gingivalis, S. aureus, S. pneumoniae, Klebsiella pneumonia, and P. aeruginosa, as well as Streptococcus mutans [30–32]. Cigarette smoke was also reported to increase C. albicans adhesion and growth, as well as biofilm formation [33, 34]. These effects were supported by the overexpression of EAP1, HWP1, and Sap2 genes known to be active players in C. albicans virulence [34]. By modulating C. albicans adhesion, proliferation, and biofilm formation in vitro, cigarette smoke may also modulate the yeast interaction with human cells such as fibroblasts. The aim of this study was thus to investigate the effect of cigarette smoke condensate on C. albicans transition from blastospore to hyphal form, its response to environmental stress, its production of cell wall chitin, and its interaction with human gingival fibroblasts.

2. Experimental Protocol

2.1. Candida albicans

C. albicans SC5314, known to be strongly invasive [35], was cultured for 24 h on Sabouraud dextrose agar plates (Becton Dickinson, Oakville, ON, Canada) at 30°C. For the C. albicans suspensions, one colony was used to inoculate 10 mL of Sabouraud liquid medium supplemented with 0.1% glucose, pH 5.6. The cultures were then grown in a shaking water bath for 18 h at 30°C, after which time the yeast cells were collected, washed with phosphate-buffered saline (PBS), counted by means of a haemocytometer, and adjusted to 10⁶/mL prior to use.

2.2. Gingival Fibroblast Isolation and Culture

Small biopsies of lamina propria tissue (gingival connective tissue) were collected from healthy nonsmokers (18–25 years old) following their informed consent in accordance with Laval University Ethics Committee guidelines. To isolate the gingival fibroblasts, the connective tissue was placed in a collagenase P solution (0.125 U/mL; Boehringer Mannheim, Laval, QC, Canada) for 45 min at 37°C under gentle agitation. The isolated cells (2 × 10⁵) were seeded in 75-cm² flasks (Falcon, Becton-Dickinson, Cockeysville, MD, USA) and grown in Dulbecco’s modified Eagle’s (DME) medium (Invitrogen) containing 10% fetal calf serum (Invitrogen Canada Inc., Burlington, ON, Canada). Upon 90% confluence, the gingival fibroblasts were used between passage two and four for the different experiments.

2.3. Preparation of the Cigarette Smoke Condensate

1R3F cigarettes were purchased from the Kentucky Tobacco Research & Development Center (Orlando, FL, USA) and used to prepare the cigarette smoke condensate solution. Each cigarette was placed into one end of a silicone tube linked to an Erlenmeyer flask containing 200 mL of 0.09% sodium chloride. On the other end, a second silicone tube linked to the Erlenmeyer was connected to a standard vacuum. The cigarette was attached to the cigarette holder and lit and the smoke was extracted by applying vacuum, pulling the smoke directly into the 0.09% sodium chloride solution. The procedure was repeated with a total of ten whole cigarettes. The resulting cigarette smoke condensate (CSC) solution was then sterilized by filtration through a 0.22-μm filter and subsequently stored at 4°C until use.

2.4. Effect of CSC on C. albicans Transition from Blastospore to Hyphal Form

To determine the effect of CSC on the yeast-to-hyphae transition we used qualitative and quantitative assays. C. albicans (10⁵ cells) was grown in 3 mL of Sabouraud dextrose broth supplemented with 0.1% glucose and 10% fetal bovine serum (FBS) with or without CSC at various concentrations (10, 30, and 50%). The negative controls refer to the C. albicans cultures without CSC. Different conditions were tested: (1) the hyphae-inducing conditions were previously reported [30], consisting of culture medium supplemented with 10% fetal calf serum followed by incubation at 37°C; (2) culture at 37°C, without serum; (3) culture in the presence of 10% serum at 30°C; and (4) culture at 30°C without serum. Following incubation for 3 or 6 h, the cultures were observed microscopically and photographed to record C. albicans morphology (). The density of the C. albicans transition was also measured. Furthermore, the length of the hyphal forms in each condition was measured by means of NIH-ImageJ software.

2.5. Effect of CSC on C. albicans Response to Stressful Agents

To investigate the effect of CSC on C. albicans sensitivity/resistivity, we exposed the yeast cells to oxidative, osmotic, or heat stress. To do so, C. albicans cells were cultured in Sabouraud with or without CSC at various concentrations (10, 30, or 50%). The culture medium was adjusted to have the same level of nutriments as did the control (absence of CSC). Cultures were incubated in a water bath at 30°C for 24 h under agitation. Following the incubation, the cells were counted with a haemocytometer, after which time 10⁶ cells/mL were treated with hydrogen peroxide (5, 10 or 50 mM) or NaCl (1.2 M) or heat treated at 45°C. Incubation under oxidative, osmotic, or heat stress took place for 60 min under agitation. The cells were then washed twice with sterile PBS and suspended thereafter in Sabouraud medium at 10⁶ cells/mL. The sample volume referring to 10³ or 10⁴ of each condition was spotted on Sabouraud agar and incubated at 30°C and colony growth was monitored at 24 and 48 h. Culture on a PDA plate lacking the disrupting agents was also performed and used as a growth control. Cell viability following contact with oxidative, osmotic, or heat stress was evaluated by means of the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) (MTT) assay (Sigma-Aldrich, St. Louis, MO, USA) which measures viable cells as a function of mitochondrial activity as we previously reported [34]. Absorbance (optical density, OD) was subsequently measured at 550 nm by means of an xMark microplate spectrophotometer (Bio-Rad, Mississauga, ON, Canada).

2.6. Effect of CSC on C. albicans Cell Wall Chitin Content

2.6.1. Cell Wall Isolation and Purification

C. albicans in Sabouraud medium was cultured overnight in the presence or absence of CSC at various concentrations (0, 10, 30, or 50%). Sabouraud medium was supplemented or not with 10% fetal calf serum for hyphae culture conditions. Cells were collected by centrifugation at 1200 rpm for 10 min and were then used to extract cell wall proteins. The C. albicans pellets were suspended in 500 μL of sterile PSB and supplemented with 200 μL of glass beads (0.425–0.6 mm in diameter; Sigma-Aldrich, G9268). The samples were cooled at −80°C for 60 sec before being subjected to disruption by means of a MiniBead-beater (Biospec Products, Bartlesville, OK, USA) for 2 min at 5,000 rpm. The samples were then cooled for 2 min at −80°C and the disruption cycle was repeated 15 times. The cells were then washed twice with 1 M NaCl and extracted thereafter in an SDS-MerOH extraction buffer (50 mM Tris, 2% sodium dodecyl sulphate (SDS), 0.3 M β-mercaptoethanol, and 1 mM EDTA; pH 8.0) at 100°C for 15 min. The resulting pellets were washed three times with 1 mm of PMSF in distilled water and the walls were freeze-dried, weighed, and used to determine the chitin level in each condition.

2.6.2. Chitin Quantification

The amount of chitin present in the cell wall of each sample was determined as described previously [36]. Briefly, 50 mg of each cell wall were hydrolyzed in 6N HCl for 16 h at 100°C. Following evaporation at 65°C, the samples were dissolved in sterile water (1 mL). From this solution, 0.1 mL was supplemented with 0.1 mL of 1.5N Na₂CO₃ in 4% acetylacetone and boiled (100°C) for 30 min, followed by the addition of 0.7 mL of 96% of ethanol to each sample. A volume of 0.1 mL of a solution containing 1.6 g of dimethylaminobenzaldehyde in 30 mL of HCl and 30 mL ethanol was added to each sample and the mixture was incubated for 1 h at 37°C in a dark atmosphere. Samples (3 × 200 mL) were aliquated into a 96-well plate at 200 μL/well and three wells per condition. Absorbance was measured at 520 nm by means of an xMark microplate spectrophotometer (Bio-Rad, Mississauga, ON, Canada) and compared with a standard curve of 0–200 mg of glucosamine. The glucosamine level in each sample was presented as the percentage of cell wall dried weight ().

2.7. Evaluation of CSC-Pretreated C. albicans Adherence to a Human Gingival Fibroblast Monolayer

To determine whether CSC promoted C. albicans adherence to gingival fibroblasts, cells were seeded into 6-well plates and grown at 37°C in a 5% CO₂ atmosphere until confluence, which was usually reached after four to five days. C. albicans was first treated with CSC at various concentrations for 24 h then washed twice with CSC-free culture medium. From this, 10⁵ yeast cells were put in contact with a gingival fibroblast monolayer for 3 and 6 h at 30°C. Following each culture period, the infected and noninfected fibroblast monolayers were washed three times with PBS and subjected thereafter to crystal violet staining. One milliliter of 1% w/v crystal violet solution in demineralized water was then added and the cultures were further incubated at room temperature for 15 min. Following incubation, the nonbound dye was removed from the wells by thorough washing with demineralized water, followed by drying at 37°C. Stained cells were then observed under an inverted microscope and the adherent C. albicans cells/clusters were counted and plotted as the number per mm² of fibroblast monolayer culture.

2.8. Effect of CSC on the Interaction of C. albicans with Gingival Fibroblasts

2.8.1. Evaluation of CSC-Pretreated C. albicans Transition following Contact with Human Gingival Fibroblasts

To determine whether the CSC pretreatment enhanced C. albicans transition when cultured with human gingival fibroblasts, C. albicans was grown in the presence of CSC at various concentrations for 24 h; 10⁵ CSC-pretreated yeast cells were layered onto a confluent fibroblast monolayer under hyphae-promoting conditions. This refers to the presence of 10% serum in the medium and incubation at 37°C [37] for 6 h. At the end of this incubation period, the cultures were washed twice with warm PBS and subsequently stained with crystal violet dye, as described above. The stained cells were then observed and photographed ().

2.8.2. Evaluation of CSC-Pretreated C. albicans and Gingival Fibroblasts Growth

To determine the effect of CSC-pretreated C. albicans on gingival fibroblast growth and vice versa, a transwell (contact-independent) culture system was used. The lower chamber of this culture system was seeded with gingival fibroblasts. When the cultures reached confluence, CSC-pretreated C. albicans was seeded inside the upper chamber and integrated to the culture system. The interaction of the gingival fibroblasts with the C. albicans thus took place through the culture medium. The cultures were maintained at 37°C in a 5% CO₂ humid atmosphere for either 24 or 48 h. Following each culture period, the C. albicans in the upper chamber was collected separately, and cell density was determined by MTT staining, as described above. As for the gingival fibroblasts, they were collected from the lower chamber and their growth was determined using a haemocytometer ().

2.9. Effect of CSC-Pretreated C. albicans on IL-1β Secretion by Gingival Fibroblasts

To evaluate the level of IL-1β secreted by gingival fibroblasts stimulated or not with CSC-pretreated C. albicans, supernatants were collected from each condition after 24 and 48 h and were analyzed by sandwich enzyme-linked immunosorbent assay (ELISA, R&D Systems, Minneapolis, MN, USA). The supernatants were collected in tubes containing one μL of a protease inhibitor cocktail for specific use with mammalian cell and tissue extracts (Sigma-Aldrich). Immediately after, the supernatants were centrifuged and used to measure IL-1β levels. ELISA plates were read at 450 nm and analyzed by means of a Microplate Reader Model 680 (Bio-Rad, USA). The minimum detectable concentration was under 1 pg/mL, as reported by the manufacturer. Each experiment was repeated four times and the means ± SD were calculated and presented.

2.10. Statistical Analyses

Each experiment was performed at least four times, with experimental values expressed as means ± SD. The statistical significance of the differences between the control (absence of CSC, and or absence of C. albicans) and the test (presence of CSC alone or CSC-pretreated C. albicans) values was determined by performing a one-way ANOVA. Posteriori comparisons were performed using Tukey’s method. Normality and variance assumptions were verified using the Shapiro-Wilk test and the Brown and Forsythe test, respectively. All of the assumptions were fulfilled. values were declared significant at ≤0.05. The data were analyzed by means of the SAS version 8.2 statistical package (SAS Institute Inc., Cary, NC, USA).

3. Results

3.1. Cigarette Smoke Condensate Promoted C. albicans Transition from Blastospore to Hyphae Forms

Previously we reported that CSC promoted C. albicans growth [34]. Candida growth was supported by the transition from blastospore to hyphal form. As shown in Figure 1(a), form change was basically observable at 6 h of culture under specific hyphal conditions (presence of serum at 37°C). Indeed, hyphae numbers appeared to be greater with CSC than with the control. The transition was obtained with all CSC concentrations with the incubation at 37°C. Incubation time was also a factor, as hyphal forms were well-defined and were more frequent at 6 h than at 3 h of incubation. Hyphae size also differed in the presence of CSC when C. albicans was cultured in the presence of serum at 37°C. As shown in Figure 1(b), longer hyphal tubes were found at 3 and 6 h. It is important to note that CSC induced longer hyphae at as early as 3 h of incubation, with a significantly () longer size observed compared to the control (absence of CSC). The hyphal tubes were longer at 6 h of incubation than at 3 h. Overall data thus demonstrate that cigarette smoke favored C. albicans growth and transition.

(a)

(b)

Figure 1: C. albicans transition from blastospore to hyphal form following contact with CSC. C. albicans was cultured with or without CSC at various concentrations for 3 or 6 h at 37°C in a culture medium supplemented with 10% serum. Following each time point, the cultures were observed under an inverted microscope and photographed (panel (a)). Hyphal tube length was measured by means of NIH-ImageJ software () and presented (panel (b)). Significance was obtained by comparing the CSC-pretreated and untreated C. albicans.

3.2. CSC Decreased C. albicans Resistance to Oxidative Stress and Increased Its Resistance to Osmotic and Heat Stress

As shown in Figure 2, following one hour of contact with 5 or 10 mM of hydrogen peroxide, C. albicans showed a marked decrease in resistance. Without CSC, a reduced colony size was observed following treatment, compared to nontreated samples. The decrease in colony size was greater when C. albicans was precultured for 24 h with CSC. The effect was dependent on the hydrogen peroxide concentrations. It should be noted that at 50 mM of hydrogen peroxide, no colony was observed with either 5 or 10 μL of seeding volume (data not shown). Interestingly, when CSC-treated C. albicans was subjected to osmotic stress, an increased resistance was observed. As shown in Figure 2, colony size was greater with 1.2 M NaCl treated Candida as compared to nontreated cells. The same observation can be made with heat stress (Figure 2). These data were supported by cell viability as ascertained by MTT assay. As shown in Figure 3, hydrogen peroxide significantly () decreased the cell viability of nonprimed or CSC-primed C. albicans. However, the decrease in cell viability was greater following hydrogen peroxide stress. Furthermore, this reduced cell viability was dependent on the hydrogen peroxide concentration used (Figure 3). Contrary to oxidative stress, osmotic and heat stress had no negative effect on cell viability. As shown in Figure 4(a), osmotic stress led to a significant () increase of C. albicans density, particularly with high levels of CSC (30 and 50%). The same effect was obtained under heat stress (Figure 4(b)).

Figure 2: Susceptibility of CSC-treated C. albicans to a cell surface-disrupting oxidative, osmotic, and thermal stress agents. Cells were treated or not with CSC then washed and suspended in H₂O₂, NaCl, or heat (45°C) for 60 min and then washed and spotted onto Sabouraud agar. Note the increased sensitivity of the CSC-treated C. albicans to 5 and 10 mM of H₂O₂, but the increased resistance was to osmotic and thermal stresses.

Figure 3: Oxidative stress reduced the growth of the CSC-pretreated C. albicans. CSC-pretreated C. albicans was washed and 10⁶ cells/mL were incubated with various concentrations of H₂O₂ for 1 h. The cells were then washed twice with warm medium and used to ascertain cell viability by MTT assay (). Significance was determined by comparing the CSC-pretreated and untreated C. albicans.

(a)

(b)

Figure 4: Osmotic and heat stresses increased the growth of CSC-pretreated C. albicans. CSC-pretreated C. albicans was washed and 10⁶ cells/mL were incubated with NaCl (1.2 M) or at 45°C for 1 h. The cells were then washed twice with warm medium and used to ascertain cell viability by MTT assay (). Significance was determined by comparing the CSC-pretreated and untreated C. albicans.

3.3. Exposure of C. albicans to CSC Increased Chitin Content

Figure 5 reveals that the growth of C. albicans yeast cells in the presence of CSC resulted in elevated chitin content. Exposure of C. albicans to CSC under a non-hyphae-inducing culture condition (absence of serum and culture at 30°C) showed a slight increase and significant chitin content in CSC-exposed C. albicans, compared to that observed with the nonexposed cells. Chitin production thus increased under normal hyphae culture conditions compared to nonhyphae culture conditions, suggesting that hyphal conditions promoted chitin synthesis. When exposed to CSC, C. albicans cells showed significantly () greater levels of chitin than did the control. This increase was more important with higher concentrations of CSC (Figure 5).

Figure 5: Chitin content in the nonexposed and CSC-exposed C. albicans. The glucosamine released from the purified cell walls following acid hydrolysis was quantified and expressed as a percentage of cell wall dried weight. Data presented are from four independent assays performed in triplicate. Significance at was determined by comparing the nonexposed and CSC-exposed yeast cells.

3.4. CSC-Pretreated C. albicans Adhered Better and Changed Form When in Contact with the Gingival Fibroblast Monolayer

To investigate whether or not CSC modulated the interaction of C. albicans with human gingival fibroblasts, C. albicans was pretreated with CSC and its adhesion to a gingival fibroblast monolayer culture at 30°C was analyzed. As shown in Figure 6(a), an elevated number of adherent C. albicans colonies were observed in the gingival fibroblast monolayers placed in contact with CSC-pretreated C. albicans. These colonies contained more than four yeast cells with a mixture of blastospore and hyphal forms. Quantitative measurement of the colonies per mm² of fibroblast monolayer culture revealed (Figure 6(b)) a significantly high number of colonies in the CSC-pretreated conditions, compared to the CSC-untreated conditions. These high levels of adherent C. albicans on the gingival fibroblast monolayers were apparent with each tested CSC concentration. Furthermore, under the hyphae culture conditions, all of the C. albicans showed an elongated tube adhering to each culture surface, with a higher hyphal form density observed in the CSC-culture conditions compared to the non-CSC ones (Figure 7). Overall data suggest that CSC promoted C. albicans adhesion and transition when interacting with human gingival fibroblast monolayers.

(a)

(b)

Figure 6: CSC-pretreated C. albicans adhered more to gingival fibroblasts. C. albicans was incubated for 24 h in the presence of CSC and then used to infect gingival fibroblast cultures for 3 or 6 h. Each culture condition was photographed following crystal violet staining (panel (a), photos after 6 h). Adherent C. albicans colonies were counted under an inverted microscope and plotted (panel (b), ). Significance was obtained by comparing the CSC-pretreated and untreated C. albicans.

Figure 7: Transition of CSC-pretreated C. albicans following contact with gingival fibroblasts. C. albicans was incubated for 24 h in the presence of CSC and then used to infect gingival fibroblast cultures for 6 h under hyphal transformation conditions (presence of 10% serum at 37°C). Each culture condition was photographed following crystal violet staining. Note the high level of C. albicans hyphae. Representative photos are from 4 different independent experiments.

3.5. CSC-Pretreated C. albicans Proliferated Better When Interacting with the Gingival Fibroblasts

As shown in Figure 8, the proliferation of CSC-pretreated C. albicans increased significantly after 24 h of interaction with the gingival fibroblasts. However, this growth was greater at 48 h than at 24 h. Figure 8 shows that a significant () growth increase of C. albicans occurred with as low as 10% CSC, compared to the control, at 48 h. The highest growth rates were obtained with 30 and 50% CSC.

Figure 8: Growth of CSC-pretreated C. albicans following contact with gingival fibroblasts. C. albicans was incubated for 24 h in the presence of CSC and then used to infect gingival fibroblast cultures for 24 or 48 h at 37°C. The cultures were performed in a transwell culture system allowing for indirect contact between C. albicans and the fibroblasts. C. albicans cells were then collected and subjected to an MTT colorimetric assay ().

3.6. CSC-Pretreated C. albicans Decreased Gingival Fibroblast Growth and Increased IL-1β Secretion

The indirect effect of CSC-pretreated C. albicans on gingival human fibroblasts was investigated using a transwell culture system. As shown in Figure 9(a), the number of viable fibroblasts at 24 h was significantly () low with the 30 and 50% CSC concentrations, compared to the control. However, at 48 h, even the 10% CSC concentration led to a significant () decrease in cell numbers. Of interest is that no detaching cells were observed in the cultures with and without CSC-pretreated C. albicans. The reduced number was, therefore, not the consequence of apoptotic/necrotic detaching cells but rather the result of a reduction in growth rate. This decreased fibroblast number (due to the interaction with CSC-pretreated C. albicans) may lead to the reduction of anti-inflammatory activity of gingival fibroblasts. To test this, we measured the level of IL-1β secreted by fibroblasts interacting with CSC-pretreated C. albicans. As shown in Figure 9(b), after 24 h of contact, the approximate concentration of IL-1β secreted by the gingival fibroblasts infected with CSC-untreated C. albicans was 30 pg/10⁴ fibroblasts. This increased to almost 40 pg/10⁴ fibroblasts following contact with 30% CSC-pretreated C. albicans and to over 40 pg/10⁴ fibroblasts with 50% CSC-pretreated C. albicans. IL-1β secretion was greater after 48 h of contact between the fibroblasts and the CSC-pretreated C. albicans, reaching close to 100 pg/10⁴ fibroblasts with 50% CSC-pretreated C. albicans. The number of viable cells decreased, however, in the presence of CSC-pretreated C. albicans (Figure 9(a)) and their secretion of IL-1β was elevated (Figure 9(b)).

(a)

(b)

Figure 9: CSC-pretreated C. albicans decreased gingival fibroblast growth. Cell cultures were pulsed with CSC-pretreated or untreated C. albicans for 24 or 48 h in a transwell culture system (panel (a)) = Fibroblasts were then trypsinized and viable/cell numbers were determined by trypan blue exclusion assay () (panel (b)) = Culture medium in each condition was used to measure the level of IL-1β by ELISA ().

4. Discussion

In a previous study, we demonstrated that the growth rate of C. albicans increased when it was cultured in the presence of CSC [34]. This is supported by the present study showing greater C. albicans morphological changes in the presence of CSC than in nonexposed controls.

One of the reasons for Candida pathogenesis is its ability to interchange between blastospore and hyphal form. Hyphae are considered necessary for invasive growth, while blastospores are considered a clonal expansion form [38]. By promoting C. albicans growth and transition, CSC may contribute to C. albicans resistance against different stress agents such as oxidative, osmotic, and heat stress. In this study, we demonstrated that CSC-pretreated C. albicans was sensitive to H₂O₂ but was resistant to osmotic and thermal stress agents. This suggests that treatment with CSC selectively confers resistance of C. albicans to some stressful agents but not to others.

It has been reported that C. albicans is relatively resistant to reactive oxygen species (ROS), tolerating up to 20 mM of H₂O₂ under specific conditions [39]. This oxidative resistance involves AP-1-like transcription factor Cap1 through the Skn7 response regulator [40]; however, these data were generated under adaptive condition of C. albicans, which differs from our CSC-exposure experiment. We thus hypothesize that under our conditions, C. albicans sensed several stressful components in the CSC and adapted to them, but when in contact with a new and strong stress agent such as H₂O₂, it was no longer capable of preventing the damaging effect of this stress agent. Further mechanistic studies will confirm this and shed light on the signaling molecules and death pathway involved. Of interest is that the CSC-pretreated C. albicans displayed resistance to osmotic and heat stress. The mechanisms underlying such resistance are still to be investigated. These may include mitogen-activated protein (MAP) kinase pathway involved in osmoadaptation in other yeasts [41, 42]. Further studies are required to demonstrate the signaling mechanisms involved in CSC-pretreated C. albicans responses against stresses.

Cell wall proteins are involved in the sensing of stressful agents [43]. These are known to play a key role in yeast cell pathogenesis [43]. Since we demonstrated that CSC-pretreated C. albicans produced more chitin, this can be considered as a protective pathway used by Candida to overcome the damaging effect of CSC by modulating the cell walls. Indeed, it has been reported that fungi can overcome damaged cell walls by increasing chitin content to maintain cell wall integrity [44]. In vitro exposure of C. albicans or A. fumigates to echinocandins was shown to lead to a compensatory increase in chitin content [45, 46]. Thus the elevated chitin biosynthesis demonstrated in the present study may be considered as a potential mechanism of resistance or tolerance against the effects of CSC. This may translate to a significant clinical impact for smokers, as C. albicans cells with a high level of chitin reportedly reduced susceptibility to antifungi such as caspofungin and echinocandins [47].

Cell wall proteins are known to play key role in the interaction between the yeast cells and the host through adhesion processes [17]. C. albicans adhesion to host cells/tissue is a key factor promoting oral yeast carriage and possible infections [48]. This adhesion may be increased in the presence of cigarette smoke, as demonstrated in the present study, in which CSC-pretreated C. albicans adhered better to gingival fibroblast monolayers than did CSC-untreated C. albicans. CSC has been shown to favor the adhesion of S mutans to dental materials [49] and of C albicans on various materials [49]. We thus demonstrate, for the first time, the significant adhesion of C. albicans to gingival fibroblasts following contact with CSC. This supports previously reported research with cigarette smoke chemicals, showing the influence of nicotine on bacterial adhesion to soft tissues [50].

By adhering to gingival fibroblasts, C. albicans may have the appropriate conditions to proliferate. Indeed, the present study shows the increased growth of CSC-pretreated C. albicans when in contact with human gingival fibroblasts. This may be due to the susceptibility of fibroblasts to CSC-pretreated C. albicans as previously reported with non-CSC-pretreated yeast cells [51].

Contact with host cells can be mediated by the fungal cell wall, an essential structure that provides physical strength and protects the fungus from hostile environments [52], including C. albicans protection against host cell inflammatory response [53]. The mechanisms underlying this process must be further examined.

The indirect interaction of gingival fibroblasts with CSC-pretreated C. albicans led to a decrease in the number of viable gingival fibroblasts. It is suggested that this decrease was not due to cell death through the detachment from the culture plate but was rather, most likely, due to a decrease in the cell growth rate. Further research will undoubtedly shed light on this process.

Interestingly, after being in contact with CSC-pretreated C. albicans, viable fibroblasts actively secreted IL-1β. Indeed, when comparing Figure 9(a) related to the cell growth and Figure 9(b) related to IL-1β secretion, a reverse image can be seen, where the lower number of viable fibroblasts corresponds to a high level of IL-1β secretion. The importance of IL-1β in protecting the mammalian host from invasive C. albicans infection has been clearly demonstrated, as mice deficient in IL-1β experienced decreased survival levels and increased fungal burdens relative to wild-type mice [54, 55]. The presence of CSC may thus contribute to the interaction of C. albicans with human gingival fibroblasts, leading to fibroblast stimulation and IL-1β secretion to overcome the damaging effect of CSC and C. albicans, as the C. albicans untreated with CSC led to low level of IL-1β secretion by the fibroblasts. This high level of IL-1β may support fibroblast protection against CSC-pretreated C. albicans virulence.

5. Conclusion

Cigarette smoke promoted C. albicans transition from blastospore to hyphal form. CSC-pretreated C. albicans was sensitive to oxidative stress but was resistant to osmotic and heat stresses. The CSC-pretreated C. albicans also displayed high levels of chitin, particularly under hyphae culture conditions. In addition, CSC modulated C. albicans interaction with the host by increasing the adhesion of this yeast to and proliferation on gingival fibroblasts. Contact with CSC-pretreated C. albicans affected the fibroblasts which exhibited a reduced growth rate and increased IL-1β secretion. Overall, this study suggests that cigarette smoke may promote C. albicans pathogenesis, supporting both the increased persistence of this pathogen in smokers and the severity of candidiasis.

Conflict of Interests

The authors declare that they have no competing interests.

Authors’ Contribution

Mahmoud Rouabhia, Witold Chmielewski, and Andrew Zakrzewski conceived the study. Humidah Alanazi, Abdelhabib Semlali, and Laura Perraud conducted the experiments. Humidah Alanazi, Abdelhabib Semlali, Laura Perraud, and Mahmoud Rouabhia analyzed and interpreted the data. Humidah Alanazi, Laura Perraud, and Abdelhabib Semlali drafted the Materials and Methods section. Mahmoud Rouabhia completed the paper with the help of Witold Chmielewski and Andrew Zakrzewski. All of the authors read and approved the final paper.

Acknowledgments

This study was supported by funding’s from the Fonds Émile Beaulieu, Laval University Foundation, and from the NSTIP Strategic Technologies Program (number 12 MED 2443) in the Kingdom of Saudi Arabia. Ms. Humidah Alanazi is a Master student, recipient of a financial support from King Saud University (Saudi Arabia) for research training. The authors thank Ms. Claire Kingston (Traduction-CFK) for proofreading and editing this paper.

References

C. C. Villar and A. Dongari-Bagtzoglou, “Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis,” Expert Reviews in Molecular Medicine, vol. 10, no. 29, article e29, 2008.

F. C. Odds, “Molecular phylogenetics and epidemiology of candida albicans,” Future Microbiology, vol. 5, no. 1, pp. 67–79, 2010.

R. A. Clift, “Candidiasis in the transplant patient,” The American Journal of Medicine, vol. 77, no. 4, pp. 34–38, 1984.

L. Knight and J. Fletcher, “Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus,” Journal of Infectious Diseases, vol. 123, no. 4, pp. 371–377, 1971.

O. P. Almeida and C. Scully, “Fungal infections of the mouth,” Brazilian Journal of Oral Sciences, vol. 1, pp. 19–26, 2002.

N. Galai, L. P. Park, J. Wesch, et al., “Effect of smoking on the clinical progression of HIV-1 infection,” Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, vol. 14, pp. 451–458, 1997.

D. Greenspan, E. Komaroff, M. Redford et al., “Oral mucosal lesions and HIV viral load in the Women's interagency HIV study (WIHS),” Journal of Acquired Immune Deficiency Syndromes, vol. 25, no. 1, pp. 44–50, 2000.

D. E. Oliver and E. J. Shillitoe, “Effects of smoking on the prevalence and intraoral distribution of Candida albicans.,” Journal of oral pathology, vol. 13, no. 3, pp. 265–270, 1984.

A. M. Willis, W. A. Coultert, C. R. Fultont, J. R. Hayes, P. M. Bell, and P. J. Lamey, “Oral candidal carriage and infection in insulin-treated diabetic patients,” Diabetic Medicine, vol. 16, no. 8, pp. 675–679, 1999.

D. K. Daftary, F. S. Mehta, P. C. Gupta, and J. J. Pindborg, “The presence of Candida in 723 oral leukoplakias among Indian villagers,” Scandinavian Journal of Dental Research, vol. 80, no. 1, pp. 75–79, 1972.

N. W. Johnson and C. A. Bain, “Tobacco and oral disease. EU-Working Group on Tobacco and Oral Health,” British Dental Journal, vol. 189, pp. 200–206, 2000.

E. Ortega, C. Barriga, and A. B. Rodríguez, “Decline in the phagocytic function of alveolar macrophages from mice exposed to cigarette smoke,” Comparative Immunology, Microbiology and Infectious Diseases, vol. 17, no. 1, pp. 77–84, 1994.

C. C. Hsia, T. T. Sun, Y. Y. Wang, et al., “Enhancement of formation of esophageal carcinogen benzylmethylnitrosoamine from its precursors by albicans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 78, pp. 1878–1881, 1981.

P. Krogh, B. Hald, and P. Holmstrup, “Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine,” Carcinogenesis, vol. 8, no. 10, pp. 1543–1548, 1987.

H. Park, Y. Liu, N. Solis et al., “Transcriptional responses of Candida albicans to epithelial and endothelial cells,” Eukaryotic Cell, vol. 8, no. 10, pp. 1498–1510, 2009.

K. Zakikhany, J. R. Naglik, A. Schmidt-westhausen, G. Holland, M. Schaller, and B. Hube, “In vivo transcript profiling of Candida albicans identifies a gene essential for interepithelial dissemination,” Cellular Microbiology, vol. 9, no. 12, pp. 2938–2954, 2007.

A. Plaine, L. Walker, G. Da Costa et al., “Functional analysis of Candida albicans GPI-anchored proteins: roles in cell wall integrity and caspofungin sensitivity,” Fungal Genetics and Biology, vol. 45, no. 10, pp. 1404–1414, 2008.

S. J. Free, “Fungal cell wall organization and biosynthesis,” Advances in Genetics, vol. 81, pp. 33–82, 2013.

C. Roncero, “The genetic complexity of chitin synthesis in fungi,” Current Genetics, vol. 41, no. 6, pp. 367–378, 2002.

J. Ruiz-Herrera, J. Manuel González-Prieto, and R. Ruiz-Medrano, “Evolution and phylogenetic relationships of chitin synthases from yeasts and fungi,” FEMS Yeast Research, vol. 1, no. 4, pp. 247–256, 2002.

N. A. R. Gow, P. W. Robbins, J. W. Lester et al., “A hyphal-specific chitin synthase gene (CHS2) is not essential for growth, dimorphism, or virulence of Candida albicans,” Proceedings of the National Academy of Sciences of the United States of America, vol. 91, no. 13, pp. 6216–6220, 1994.

J. Ruiz-Herrera, M. Victoria Elorza, E. Valentín, and R. Sentandreu, “Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity,” FEMS Yeast Research, vol. 6, no. 1, pp. 14–29, 2006.

T. Mio, T. Yabe, M. Sudoh et al., “Role of three chitin synthase genes in the growth of Candida albicans,” Journal of Bacteriology, vol. 178, no. 8, pp. 2416–2419, 1996.

C. Bromuro, A. Torosantucci, M. J. Gomez, F. Urbani, and A. Cassone, “Differential release of an immunodominant 65 kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans,” Journal of Medical and Veterinary Mycology, vol. 32, no. 6, pp. 447–459, 1994.

M. Rouabhia, M. Schaller, C. Corbucci et al., “Virulence of the fungal pathogen Candida albicans requires the five isoforms of protein mannosyltransferases,” Infection and Immunity, vol. 73, no. 8, pp. 4571–4580, 2005.

P. C. Lekic, N. Pender, and C. A. McCulloch, “Is fibroblast heterogeneity relevant to the health, diseases, and treatments of periodontal tissues?” Critical Reviews in Oral Biology and Medicine, vol. 8, no. 3, pp. 253–268, 1997.

P. M. Bartold and D. R. Haynes, “Interleukin-6 production by human gingival fibroblasts.,” Journal of Periodontal Research, vol. 26, no. 4, pp. 339–345, 1991.

H. J. Sismey-Durrant and R. M. Hopps, “Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1-beta release from rat periosteal and human gingival fibroblasts in vitro.,” Oral microbiology and immunology, vol. 6, no. 6, pp. 378–380, 1991.

H. Mehta, K. Nazzal, and R. T. Sadikot, “Cigarette smoking and innate immunity,” Inflammation Research, vol. 57, no. 11, pp. 497–503, 2008.

J. Bagaitkar, D. R. Demuth, C. A. Daep, D. E. Renaud, D. L. Pierce, and D. A. Scott, “Tobacco upregulates P. gingivalis fimbrial proteins which induce TLR2 hyposensitivity,” PLoS ONE, vol. 5, no. 5, Article ID e9323, 2010.

N. D. Mutepe, R. Cockeran, H. C. Steel et al., “Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin,” European Respiratory Journal, vol. 41, no. 2, pp. 392–395, 2013.

Y.-H. Li, P. C. Y. Lau, N. Tang, G. Svensäter, R. P. Ellen, and D. G. Cvitkovitch, “Novel two-component regulatory system involved in biofilm formation and acid resistance in Streptococcus mutans,” Journal of Bacteriology, vol. 184, no. 22, pp. 6333–6342, 2002.

F. B. Baboni, D. Barp, A. C. S. de Azevedo Izidoro, L. P. Samaranayake, and E. A. R. Rosa, “Enhancement of Candida albicans virulence after exposition to cigarette mainstream smoke,” Mycopathologia, vol. 168, no. 5, pp. 227–235, 2009.

A. Semlali, K. Killer, H. Alanazi, W. Chmielewski, and M. Rouabhia, “Cigarette smoke condensate increases C. albicans adhesion, growth, biofilm formation, and EAP1, HWP1 and SAP2 gene expression,” BMC Microbiology, vol. 14, no. 1, article 61, 2014.

A. M. Gillum, E. Y. H. Tsay, and D. R. Kirsch, “Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S.cerevisiae ura3 and E. coli pyrF mutations,” Molecular and General Genetics, vol. 198, no. 1, pp. 179–182, 1984.

C. A. Munro, R. K. Whitton, H. B. Hughes, M. Rella, S. Selvaggini, and N. A. R. Gow, “CHS8 —a fourth chitin synthase gene of Candida albicans contributes to in vitro chitin synthase activity, but is dispensable for growth,” Fungal Genetics and Biology, vol. 40, no. 2, pp. 146–158, 2003.

L. Li, C. Zhang, and J. B. Konopka, “A Candida albicans temperature-sensitive cdc12-6 mutant Identifies roles for septins in selection of sites of germ tube formation and hyphal morphogenesis,” Eukaryotic Cell, vol. 11, no. 10, pp. 1210–1218, 2012.

J. Karkowska-Kuleta, M. Rapala-Kozik, and A. Kozik, “Fungi pathogenic to humans: Molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus,” Acta Biochimica Polonica, vol. 56, no. 2, pp. 211–224, 2009.

D. J. Jamieson, D. W. S. Stephen, and E. C. Terrière, “Analysis of the adaptive oxidative stress response of Candida albicans,” FEMS Microbiology Letters, vol. 138, no. 1, pp. 83–88, 1996.

P. Singh, N. Chauhan, A. Ghosh, F. Dixon, and R. Calderone, “SKN7 of Candida albicans: mutant construction and phenotype analysis,” Infection and Immunity, vol. 72, no. 4, pp. 2390–2394, 2004.

E. Nikolaou, I. Agrafioti, M. Stumpf, et al., “Phylogenetic diversity of stress signalling pathways in fungi,” BMC Evolutionary Biology, vol. 9, article 44, pp. 1–18, 2009.

D. A. Smith, B. A. Morgan, and J. Quinn, “Stress signalling to fungal stress-activated protein kinase pathways,” FEMS Microbiology Letters, vol. 306, no. 1, pp. 1–8, 2010.

A. J. P. Brown, S. Budge, D. Kaloriti et al., “Stress adaptation in a pathogenic fungus,” Journal of Experimental Biology, vol. 217, part 1, pp. 144–155, 2014.

C. A. Munro, S. Selvaggini, I. de Bruijn et al., “The PKC, HOG and Ca2+ signalling pathways co-ordinately regulate chitin synthesis in Candida albicans,” Molecular Microbiology, vol. 63, no. 5, pp. 1399–1413, 2007.

L. A. Walker, C. A. Munro, I. De Bruijn, M. D. Lenardon, A. McKinnon, and N. A. R. Gow, “Stimulation of chitin synthesis rescues Candida albicans from echinocandins,” PLoS Pathogens, vol. 4, no. 4, Article ID e1000040, 2008.

J. R. Fortwendel, P. R. Juvvadi, N. Pinchai et al., “Differential effects of inhibiting chitin and 1,3-β-D-glucan synthesis in Ras and calcineurin mutants of Aspergillus fumigatus,” Antimicrobial Agents and Chemotherapy, vol. 53, no. 2, pp. 476–482, 2009.

K. K. Lee, D. M. MacCallum, M. D. Jacobsen et al., “Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo,” Antimicrobial Agents and Chemotherapy, vol. 56, no. 1, pp. 208–217, 2012.

F. Dalle, B. Wächtler, C. L'Ollivier et al., “Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes,” Cellular Microbiology, vol. 12, no. 2, pp. 248–271, 2010.

F. B. Baboni, O. Guariza Filho, A. N. Moreno, and E. A. R. Rosa, “Influence of cigarette smoke condensate on cariogenic and candidal biofilm formation on orthodontic materials,” The American Journal of Orthodontics and Dentofacial Orthopedics, vol. 138, no. 4, pp. 427–434, 2010.

W. Teughels, J. Van Eldere, D. van Steenberghe, J.-J. Cassiman, P. Fives-Taylor, and M. Quirynen, “Influence of nicotine and cotinine on epithelial colonization by periodontopathogens,” Journal of Periodontology, vol. 76, no. 8, pp. 1315–1322, 2005.

G. J. Merkel and C. L. Phelps, “Factors influencing the interaction of Candida albicans with fibroblast cell cultures,” Infection and Immunity, vol. 56, no. 4, pp. 792–801, 1988.

W. L. Chaffin, “Candida albicans cell wall proteins,” Microbiology and Molecular Biology Reviews, vol. 72, no. 3, pp. 495–544, 2008.

N. S. Soysa and A. N. B. Ellepola, “The impact of cigarette/tobacco smoking on oral candidosis: an overview,” Oral Diseases, vol. 11, no. 5, pp. 268–273, 2005.

A. G. Hise, J. Tomalka, S. Ganesan et al., “An essential role for the NLRP3 inflammasom e in host defense against the human fungal pathogen Candida albicans,” Cell Host and Microbe, vol. 5, no. 5, pp. 487–497, 2009.

A. G. Vonk, M. G. Netea, J. H. Van Krieken, Y. Iwakura, J. W. M. Van Der Meer, and B. J. Kullberg, “Endogenous interleukin (IL)-1α and IL-1β are crucial for host defense against disseminated candidiasis,” Journal of Infectious Diseases, vol. 193, no. 10, pp. 1419–1426, 2006.